KALA vs MDT · $54.3M cap vs P/E 21, rev $36.36B
Kala Pharmaceuticals Inc (KALA) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Medtronic PLC (MDT) is a medical devices company listed on US.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
KALA currently screens at market cap $54.3M. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the KALA and MDT stock pages for the full models.
Not investment advice.